📣 VC round data is live. Check it out!

Crescent Capital BDC Valuation Multiples

Discover revenue and EBITDA valuation multiples for Crescent Capital BDC and similar public comparables like Ophir High Conviction, Idun Industrier, International Biotechnology Trust, Bosqar and more.

Crescent Capital BDC Overview

About Crescent Capital BDC

Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.


Founded

2015

HQ

United States

Employees

230

Financials (LTM)

Revenue: $161M
Net Income: $35M

EV

$1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Crescent Capital BDC Financials

Crescent Capital BDC reported last 12-month revenue of $161M.

In the same LTM period, Crescent Capital BDC generated $35M in net income.

Revenue (LTM)


Crescent Capital BDC P&L

In the most recent fiscal year, Crescent Capital BDC reported revenue of $167M and net income of $35M.

Crescent Capital BDC is profitable as of last fiscal year, with net margin of 21%.

See analyst estimates for Crescent Capital BDC
LTMLast FY202320242025202620272028
Revenue$161M$167M$92M$84M$47M
EBIT Margin40%40%141%
Net Profit$35M$35M$84M$74M$35M
Net Margin22%21%91%88%73%
Net Debt$869M

Financial data powered by Morningstar, Inc.

Crescent Capital BDC Stock Performance

Crescent Capital BDC has current market cap of $419M, and enterprise value of $1B.

Market Cap Evolution


Crescent Capital BDC's stock price is $11.38.

Crescent Capital BDC share price decreased by 16.4% in the last 30 days, and by 26.7% in the last year.

Crescent Capital BDC has an EPS (earnings per share) of $0.94.

See more trading valuation data for Crescent Capital BDC
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1B$419M0.0%-16.4%-10.1%-26.7%$0.94

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Crescent Capital BDC Valuation Multiples

Crescent Capital BDC trades at 8.2x EV/Revenue multiple.

See NTM and 2027E valuation multiples for Crescent Capital BDC

EV / Revenue (LTM)


Crescent Capital BDC Financial Valuation Multiples

As of May 25, 2026, Crescent Capital BDC has market cap of $419M and EV of $1B.

Crescent Capital BDC has a P/E ratio of 12.0x.

LTMLast FY202320242025202620272028
EV/Revenue8.2x7.9x14.3x15.9x28.0x
EV/EBIT20.6x19.8x19.8x
P/E12.0x12.2x5.0x5.7x12.2x
EV/FCF17.8x14.4x22.5x17.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Crescent Capital BDC Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Crescent Capital BDC Margins & Growth Rates

Crescent Capital BDC decreased revenue by 10% but net profit grew by 4% in the last fiscal year.

In the most recent fiscal year, Crescent Capital BDC reported net margin of 21%.

See estimated margins and future growth rates for Crescent Capital BDC

Crescent Capital BDC Margins

Last FY202420252026202720282029
EBIT Margin40%141%40%
Net Margin21%88%73%24%
FCF Margin45%71%158%

Crescent Capital BDC Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(10%)(10%)(43%)219%
EBIT Growth(10%)(10%)
Net Profit Growth4%(12%)(53%)4%
FCF Growth(36%)27%

Data powered by FactSet, Inc. and Morningstar, Inc.

Crescent Capital BDC Operational KPIs

Crescent Capital BDC's revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.4M for the same period.

Access forward-looking KPIs for Crescent Capital BDC
LTMLast FY202320242025202620272028
Revenue per Employee$0.7M
Opex per Employee$0.4M
G&A Expenses to Revenue3%4%5%6%15%
Opex to Revenue54%53%9%10%24%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Crescent Capital BDC Competitors

Crescent Capital BDC competitors include Ophir High Conviction, Idun Industrier, International Biotechnology Trust, Bosqar, Metrics Income Opportunities Trust, Whitefield Industrials, Fiera Capital, Gladstone Cap, MCI Capital and Fundo DE Investimento.

Most Crescent Capital BDC public comparables operate across Asset Management.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Ophir High Conviction3.5x
Idun Industrier2.1x2.0x13.0x12.1x
International Biotechnology Trust(1975.9x)
Bosqar1.7x14.4x
Metrics Income Opportunities Trust8.9x
Whitefield Industrials21.9x
Fiera Capital2.0x2.0x6.8x6.7x
Gladstone Cap9.2x8.5x

This data is available for Pro users. Sign up to see all Crescent Capital BDC competitors and their valuation data.

Start Free Trial

Crescent Capital BDC M&A Activity

Crescent Capital BDC has acquired 1 company to date.

Last acquisition by Crescent Capital BDC was on August 13th 2019. Crescent Capital BDC acquired Alcentra Capital Corporation for $142M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Crescent Capital BDC

Alcentra Capital Corporation
Description
Alcentra Capital Corporation is a New York-headquartered business development company founded in 2007 that provides subordinated debt, senior loans, and equity to lower middle-market companies in the United States. Regulated under the Investment Company Act, it targets firms with EBITDA of $10-50 million, generating income through a diversified portfolio of over 20 investments.
HQ CountryUnited States
HQ City
New York City, NY
Deal Date13 Aug 2019
Valuation$142M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Crescent Capital BDC acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Crescent Capital BDC

When was Crescent Capital BDC founded?Crescent Capital BDC was founded in 2015.
Where is Crescent Capital BDC headquartered?Crescent Capital BDC is headquartered in United States.
How many employees does Crescent Capital BDC have?As of today, Crescent Capital BDC has over 230 employees.
Who is the CEO of Crescent Capital BDC?Crescent Capital BDC's CEO is Jason Breaux.
Is Crescent Capital BDC publicly listed?Yes, Crescent Capital BDC is a public company listed on Nasdaq.
What is the stock symbol of Crescent Capital BDC?Crescent Capital BDC trades under CCAP ticker.
When did Crescent Capital BDC go public?Crescent Capital BDC went public in 2020.
Who are competitors of Crescent Capital BDC?Crescent Capital BDC main competitors include Ophir High Conviction, Idun Industrier, International Biotechnology Trust, Bosqar, Metrics Income Opportunities Trust, Whitefield Industrials, Fiera Capital, Gladstone Cap, MCI Capital, Fundo DE Investimento.
What is the current market cap of Crescent Capital BDC?Crescent Capital BDC's current market cap is $419M.
What is the current revenue of Crescent Capital BDC?Crescent Capital BDC's last 12 months revenue is $161M.
What is the current revenue growth of Crescent Capital BDC?Crescent Capital BDC revenue growth (NTM/LTM) is (7%).
What is the current EV/Revenue multiple of Crescent Capital BDC?Current revenue multiple of Crescent Capital BDC is 8.2x.
Is Crescent Capital BDC profitable?Yes, Crescent Capital BDC is net-income-positive (as of the last 12 months).
What is the current net income of Crescent Capital BDC?Crescent Capital BDC's last 12 months net income is $35M.
How many companies Crescent Capital BDC has acquired to date?As of May 2026, Crescent Capital BDC has acquired 1 company.
What was the largest acquisition by Crescent Capital BDC?$142M acquisition of Alcentra Capital Corporation on 13th August 2019 was the largest M&A Crescent Capital BDC has done to date.
What companies Crescent Capital BDC acquired?Crescent Capital BDC acquired Alcentra Capital Corporation.
In how many companies Crescent Capital BDC has invested to date?Crescent Capital BDC hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Crescent Capital BDC

Lists including Crescent Capital BDC

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial